Clinical Trials in San Antonio

Showing 3221-3240 of 7,028 trials

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

NCT01559363

The primary objective of this study Phase 1b was to determine the safety, plasma pharmacokinetics, and maximum tolerated dose (MTD) of tesevatinib when administered to participants with autosomal dominant polycystic kidney disease (ADPKD). The primary objective of this study Phase 2a was to evaluate the annualized change in glomerular filtration rate (GFR) in participants with ADPKD when treated with tesevatinib.

Polycystic Kidney, Autosomal Dominant

Kadmon, a Sanofi Company69 participantsStarted Oct 2012

Los Angeles, California, United States • Denver, Colorado, United States • Kansas City, Kansas, United States +8 more locations

COMPLETEDPhase 3< 1 mile

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

NCT01763866

The primary objective was to evaluate the effect of 12 weeks of evolocumab administered subcutaneously every 2 weeks (Q2W) and monthly (QM) when used in combination with a statin, compared with placebo, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in patients with primary hypercholesterolemia and mixed dyslipidemia.

Hyperlipidemia

Amgen2,067 participantsStarted Jan 2013

Birmingham, Alabama, United States • Glendale, Arizona, United States • Tucson, Arizona, United States +241 more locations

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Find Trials by Condition in San Antonio

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

The Effects of Hot Yoga on Vascular Function

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With PNH

A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC

Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD